Qfsn Pain Relief Cream
NDC 87403-001
Product Information
Qfsn Pain Relief Cream (pain relief cream) is a OTC MONOGRAPH DRUG-approved product labeled by Qiaofusheng Pharmaceuticals Co., Ltd.. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a cream for topical administration. This product entry covers the primary NDC 87403-001 and 10 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 87403-001?
What are the uses of this product?
What are Active Ingredients of this product?
- CAMPHOR (SYNTHETIC) 11 g/100g
- MENTHOL 10 g/100g - A monoterpene cyclohexanol produced from mint oils.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)
- CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET) (Active Moiety)
- MENTHOL (UNII: L7T10EIP3A)
- MENTHOL (UNII: L7T10EIP3A) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- PEPPERMINT OIL (UNII: AV092KU4JH)
- WATER (UNII: 059QF0KO0R)
- CLOVE OIL (UNII: 578389D6D0)
- EUCALYPTUS OIL (UNII: 2R04ONI662)
- CARBOMER (UNII: 0A5MM307FC)
- GLYCERYL MONO- AND DIPALMITOSTEARATE (UNII: KC98RO82HJ)
- GLYCERIN (UNII: PDC6A3C0OX)
- DIMETHICONE (UNII: 92RU3N3Y1O)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- ETHYL NITRATE (UNII: E1ZT886LR5)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 849498 - camphor 11 % / menthol 10 % Topical Cream
- RxCUI: 849498 - camphor 110 MG/ML / menthol 100 MG/ML Topical Cream
* Please review the full disclaimer at the bottom of this page.